SCHEMBL632491

SCHEMBL632491

CCOc1nc(O)nc(OCC)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
CYP1A2 P05177 1/20 0.43
TSHR P16473 3/20 0.41
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
POLB P06746 2/20 0.40
PDE4B Q07343 1/20 0.39
PDE4D Q08499 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
MAPK1 P28482 2/20 0.38
MAT2A P31153 1/20 0.38
LMNA P02545 3/20 0.36
GALR3 O60755 1/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL193671 0.95 MEN1 (0.43) MEN1KMT2ACYP1A2TSHRALDH1A1
SCHEMBL10952859 0.91 MEN1 (0.38) MEN1KMT2ACYP1A2TSHRALDH1A1
SCHEMBL582039 0.86 MEN1 (0.52) MEN1KMT2ACYP1A2TSHRALDH1A1
Acrylic Acid SCHEMBL4891585 0.78 LMNA (0.36) MEN1KMT2ACYP1A2TSHRALDH1A1
SCHEMBL11270818 0.77 LTA4H (0.42) CYP1A2TSHRSMN1; SMN2MAPK1LMNA
SCHEMBL28154430 0.77 MEN1 (0.34) MEN1KMT2ACYP1A2TSHRALDH1A1
SCHEMBL20202489 0.76 MEN1 (0.45) MEN1KMT2ACYP1A2TSHRALDH1A1
SCHEMBL4950707 0.75 LTA4H (0.36) CYP1A2ALDH1A1L3MBTL1SMN1; SMN2LMNA
SCHEMBL2118007 0.75 MEN1 (0.41) MEN1KMT2ACYP1A2TSHRALDH1A1
SCHEMBL1576984 0.74 MEN1 (0.43) MEN1KMT2ACYP1A2TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9234225-B2 Method for generating human milk oligosaccharides (HMOs) or precursors thereof GLYCOM A/S (DK) 2016-01-12 US claimed
US-20150182549-A1 METHOD FOR ENZYMATIC GLYCOSYLATION OF OLIGOSACCHARIDES FROM MAMMALIAN ANIMAL MILK GLYCOM A/S (DK) 2015-07-02 US claimed
US-20150183816-A1 MODIFIED GALACTOOLIGOSACCHARIDES GLYCOM A/S (DK) 2015-07-02 US claimed
EP-2864492-A1 MODIFIED GALACTOOLIGOSACCHARIDES Glycom A/S (DK) 2015-04-29 EP claimed
EP-2864344-A1 METHOD FOR ENZYMATIC GLYCOSYLATION OF OLIGOSACCHARIDES FROM MAMMALIAN ANIMAL MILK Glycom A/S (DK) 2015-04-29 EP claimed
US-20140234912-A1 METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF GLYCOM A/S (DK) 2014-08-21 US claimed
EP-2707493-A1 METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF Glycom A/S (DK) 2014-03-19 EP claimed
WO-2013190530-A1 MODIFIED GALACTOOLIGOSACCHARIDES GLYCOM A/S (DK) 2013-12-27 WO claimed
WO-2013190529-A1 GLYCOSYLATED GALACTOSYL DISACCHARDDES, METHODS FOR THEIR PRODUCTION AND THEIR USE IN CONSUMABLE PRODUCTS GLYCOM A/S (DK) 2013-12-27 WO claimed
WO-2013190531-A1 GLYCOSYLATED GALACTOSYL DISACCHARIDES, METHODS FOR THEIR PRODUCTION AND THEIR USE IN CONSUMABLE PRODUCTS GLYCOM A/S (DK) 2013-12-27 WO claimed
WO-2012156897-A1 METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF GLYCOM A/S (DK) 2012-11-22 WO claimed
US-3980616-A Flameproofing agent for polyamide resins MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1976-09-14 US claimed
US-11945928-B2 Polyol composition and polyurethane foam SEKISUI CHEMICAL CO., LTD. (JP) 2024-04-02 US disclosed
WO-2023113029-A1 FLAME-RETARDANT INSULATING SHEET AND ELECTRICAL/ELECTRONIC DEVICE 住友ベークライト株式会社 2023-06-22 WO disclosed
CN-115916899-A Polyamide resin composition and molded article obtained by molding same 东丽株式会社 2023-04-04 CN disclosed
US-20210355292-A1 POLYOL COMPOSITION AND POLYURETHANE FOAM SEKISUI CHEMICAL CO., LTD. (JP) 2021-11-18 US disclosed
EP-1076077-A1 Polyamide resin composition EMS Chemie AG (CH) 2001-02-14 EP disclosed
EP-1074581-A1 Layered silicate-containing composite resin composition, and moulded barrier composite resin EMS Chemie AG (CH) 2001-02-07 EP disclosed
EP-1024172-A1 FLAME-RETARDANT POLYAMIDE COMPOSITE MATERIAL WITH HIGH RIGIDITY Showa Denko Kabushiki Kaisha (JP) 2000-08-02 EP disclosed
US-3980616-A Flameproofing agent for polyamide resins MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1976-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150182549-A1 METHOD FOR ENZYMATIC GLYCOSYLATION OF OLIGOSACCHARIDES FROM MAMMALIAN ANIMAL MILK GALE, SI, FUT6 MEN1 3216/4885KMT2A 3234/4885CYP1A2 2404/4885
US-20150183816-A1 MODIFIED GALACTOOLIGOSACCHARIDES FUT6, GALE, FUT5 MEN1 3836/4885KMT2A 2432/4885CYP1A2 1992/4885
US-20140234912-A1 METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF LCT, B4GALT1, GALNT1 MEN1 1861/4885KMT2A 2757/4885CYP1A2 2967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.